Journal of Labelled Compounds and Radiopharmaceuticals

Cover image for Vol. 59 Issue 9

Editors-in-Chief: R F Dannals and K M W Lawrie

Impact Factor: 1.532

ISI Journal Citation Reports © Ranking: 2015: 42/59 (Chemistry Medicinal); 47/75 (Chemistry Analytical); 62/77 (BIOCHEMICAL RESEARCH METHODS)

Online ISSN: 1099-1344

Editorial Board


EDITORS-IN-CHIEF   

R F Dannals
Division of Nuclear Medicine
The Johns Hopkins University
600 North Wolfe Street
Nelson Bl-127
Baltimore, Maryland 21287-0816, USA
E-mail: rfd@jhu.edu


K M W Lawrie
GlaxoSmithKline
Isotope Chemistry
Medicines Research Centre
Stevenage
Herts, SG1 2NY, UK
E-mail: ken.lawrie@gsk.com

EDITORS

LABELLED COMPOUNDS EDITOR FOR NORTH AMERICA 

B D Maxwell
Bristol-Myers Squibb
P O Box 4000, Mail Stop H14-02
Princeton,

NJ 08543, USA

E-mail: brad.maxwell@bms.com


RADIOPHARMACEUTICALS EDITOR 

A D Windhorst
VUMC, Dept Radiology & Nuclear Medicine
Location Radionuclide Center
De Boelelaan 1085c
1081 HV Amsterdam, The Netherlands
E-mail: ad.windhorst@vumc.nl


LABELLED COMPOUNDS EDITOR FOR EUROPE
T Moenius

Isotope Laboratory
Novartis
Huenigerstrasse WSJ507.95
CH-4002, Basel
Switzerland
E-mail: thomas.moenius@novartis.com

RADIOPHARMACEUTICALS EDITOR
FOR NORTH AMERICA

R F Dannals
Division of Nuclear Medicine
The Johns Hopkins University
600 North Wolfe Street
Nelson Bl-127
Baltimore, Maryland 21287-0816, USA
E-mail: rfd@jhu.edu

RADIOPHARMACEUTICALS EDITOR
FOR ASIA, AUSTRALIA AND NEW ZEALAND

M Kassiou
School of Chemistry
University of Sydney
NSW 2006 Sydney
Australia
E-mail: michael.kassiou@sydney.edu.au

REVIEW EDITOR
F. Aigbirhio
Wolfson Brain Imaging Centre
University of Cambridge
Addenbrooke’s Hospital ,
Cambridge, CB2 2QQ, UK
E-mail: fia20@wbic.cam.ac.uk


ADVISORY BOARD

C Anderson
University of Pittsburgh
Pittsburgh, USA

J Atzrodt
Sanofi-Aventis
Frankfurt, Germany

M Chappelle
Quotient Bioresearch,
Cardiff, Wales, UK

D Y Chi
Sogang University,
Seoul, Korea

H H Coenen
Institute für Nuclearchemie,
Jülich, Germany

B Cornelissen
University of Oxford
Oxford, UK

F Dollé
CEA, Institut d'imagerie biomédicale,
CEA Orsay, France

C Elmore
AstraZeneca
Mölndal, Sweden

C N Filer
NEN Life Science Products, Inc.
Boston, USA

Y. Fujibayashi
National Institute of Radiological Sciences
Chiba, Japan

D Hesk
Westfield,
NJ, USA

J A Katzenellenbogen
University of Illinois at Urbana-Champaign
Urbana, USA

W Kerr
University of Strathclyde
Glasgow, UK

S Lapi
University of Alabama
Tuscaloosa, USA

B Latli
Boehringer Ingelheim
Ridgefield, USA

B Långström
Uppsala University
Uppsala, Sweden

W J S Lockley
University of Surrey
Guildford, Surrey, UK

N Long
Imperial College
London, UK

M H Marx
EaglePicher Pharmaceutical Services
Lenexa, Kansas, USA

D Muri
Roche
Basel, Switzerland

V W Pike
Molecular Imaging Branch
National Institute of Mental Health
Bethesda, MD, USA

T Rossi
Hannover Medical School
Hannover, Germany

H Saji
Kyoto University
Kyoto, Japan

R Salter
Johnson & Johnson,
Raritan, NJ 08869, USA

D Schenk
Merck
Rahway, USA

S Stone-Elander
Clinical Neurosciences Division
Karolinska Pharmacy
Stockholm, Sweden

M L Thakur
Thomas Jefferson University Hospital
Philadelphia, USA

M Venkatesh
Homi Bhabha National Institute
Mumbai, India

M R Zalutsky
Duke University Medical Center
Durham, USA

X Zhang
Center for Molecular Imaging and Translational Medicine
Xiamen University
Xiamen, China


The Journal of Labelled Compounds and Radiopharmaceuticals is the Official Journal of the International Isotope Society (IIS) http://www.intl-isotope-soc.org/

SEARCH

SEARCH BY CITATION